SN4
SHORT NOTE
5M
★ High-yield
Differentiate zero-order from first-order kinetics with examples and clinical significance.
Definitions
| Order | Definition | Equation |
|---|---|---|
| First-order kinetics | The rate of elimination is directly proportional to the plasma concentration; a constant fraction of the drug present is eliminated per unit time | Rate = k × C |
| Zero-order (saturation, Michaelis–Menten) kinetics | A constant amount of drug is eliminated per unit time, independent of the plasma concentration, because the eliminating enzymes or carriers are saturated | Rate = k (a constant) |
Comparison
| Feature | First-order | Zero-order |
|---|---|---|
| Enzyme saturation | Not saturated | Saturated |
| Amount eliminated per unit time | Varies with concentration | Constant |
| Fraction eliminated per unit time | Constant | Varies |
| Half-life | Constant and meaningful | Not constant — rises with dose; the term does not properly apply |
| Semilogarithmic plot | Straight line | Curved |
| Linear plot | Curved (exponential decay) | Straight line |
| Clearance | Constant | Falls as concentration rises |
| Doubling the dose | Doubles the steady-state concentration — predictable | Causes a much greater than twofold rise — may precipitate toxicity |
| Time to steady state | 4 to 5 half-lives | Prolonged and unpredictable |
| Applies to | The great majority of drugs at therapeutic doses | Phenytoin, ethanol, aspirin in high dose, theophylline, tolbutamide, heparin, warfarin at high dose, dicoumarol |
CLINICAL PEARL
Zero-order kinetics is dangerous because the margin between an effective and a toxic dose disappears. With phenytoin, an increase from 300 to 400 mg a day may raise the plasma level not by a third but three- or fourfold, tipping a controlled patient into nystagmus, ataxia and confusion. This is why phenytoin doses are increased in 25 to 50 mg increments once the level approaches the therapeutic range.
Drugs Showing a Change of Order
- Some drugs follow first-order kinetics at therapeutic doses and switch to zero-order once the enzymes saturate — and it is exactly this transition that makes them hazardous
- Aspirin — first-order at analgesic doses, zero-order at anti-inflammatory and toxic doses; hence the danger of salicylate poisoning
- Phenytoin — saturation occurs within the therapeutic range itself
- Ethanol is zero-order at almost all concentrations, eliminated at about 10–15 mL an hour whatever the amount consumed — which is why time is the only remedy for intoxication
- Theophylline and tolbutamide at higher doses
Applied Aspects
- Increase phenytoin in small increments and monitor levels — the single most important practical consequence of zero-order kinetics
- In salicylate poisoning, elimination is slow and unpredictable, so levels must be repeated; urinary alkalinisation and, in severe cases, haemodialysis are used
- There is no way to accelerate ethanol elimination — coffee, exercise and cold showers do nothing; only time works
- Drug levels rise disproportionately in a saturated system, so a patient who has been stable for months may become toxic after a small dose increase or after starting an enzyme inhibitor
- Steady state cannot be predicted from half-life in zero-order kinetics, so the usual rule of four to five half-lives does not apply
All questions in General Pharmacology: Pharmacokinetics
- Q1Classify the routes of drug administration. Describe their advantages and disadvantages. Add a note on the mechanisms of drug transport across membranes. ★
- Q2Define absorption and bioavailability. Describe the factors affecting them and add a note on first-pass metabolism. ★
- Q3Describe the distribution of drugs. Explain the volume of distribution, plasma protein binding and the barriers to distribution. ★
- Q4Define biotransformation. Describe phase I and phase II reactions and the factors modifying drug metabolism. ★
- Q5Describe the excretion of drugs. Explain clearance, half-life and the kinetics of elimination. Add a note on therapeutic drug monitoring. ★
- SN1Describe first-pass metabolism with its sites, consequences and clinical significance. ★
- SN2Define enzyme induction and inhibition. Compare them and describe their clinical consequences. ★
- SN3Define volume of distribution. Describe the factors affecting it and its clinical applications. ★
- SN4Differentiate zero-order from first-order kinetics with examples and clinical significance. ★
- SN5Define plasma half-life. Explain the plateau principle and the factors altering half-life. ★
- SN6Define prodrug. Give the reasons for using prodrugs with examples. ★
- SN7Classify drug interactions. Describe the pharmacokinetic and pharmacodynamic interactions with examples.